Singh JA - Search Results

1

Treatment Guidelines in Rheumatoid Arthritis.

Singh JA. Singh JA. Rheum Dis Clin North Am. 2022 Aug;48(3):679-689. doi: 10.1016/j.rdc.2022.03.005. Epub 2022 Jul 5. Rheum Dis Clin North Am. 2022. PMID: 35953230 Review.

2

Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: a report of two cases.

Singh JA, Mahowald ML. Singh JA, et al. Joint Bone Spine. 2009 Mar;76(2):190-4. doi: 10.1016/j.jbspin.2008.05.006. Epub 2008 Oct 25. Joint Bone Spine. 2009. PMID: 18952480

3

Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.

Curtis JR, Baddley JW, Yang S, Patkar N, Chen L, Delzell E, Mikuls TR, Saag KG, Singh J, Safford M, Cannon GW. Curtis JR, et al. Arthritis Res Ther. 2011;13(5):R155. doi: 10.1186/ar3471. Epub 2011 Sep 20. Arthritis Res Ther. 2011. PMID: 21933396 Free PMC article.

4

Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.

Curtis JR, Yang S, Patkar NM, Chen L, Singh JA, Cannon GW, Mikuls TR, Delzell E, Saag KG, Safford MM, DuVall S, Alexander K, Napalkov P, Winthrop KL, Burton MJ, Kamauu A, Baddley JW. Curtis JR, et al. Among authors: singh ja. Arthritis Care Res (Hoboken). 2014 Jul;66(7):990-7. doi: 10.1002/acr.22281. Arthritis Care Res (Hoboken). 2014. PMID: 24470378 Free PMC article.

5

Is Rheumatoid Arthritis a Cardiovascular Risk-Equivalent to Diabetes Mellitus?

Curtis JR, Yang S, Singh JA, Xie F, Chen L, Yun H, Muntner P, Kent ST, Levitan EB, Safford MM, Saag KG, Zhang J. Curtis JR, et al. Among authors: singh ja. Arthritis Care Res (Hoboken). 2018 Nov;70(11):1694-1699. doi: 10.1002/acr.23535. Arthritis Care Res (Hoboken). 2018. PMID: 29409152

6

Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.

Arayssi T, Harfouche M, Darzi A, Al Emadi S, A Alnaqbi K, Badsha H, Al Balushi F, Dib C, Elzorkany B, Halabi H, Hammoudeh M, Hazer W, Masri B, Merashli M, Omair M, Salloum N, Uthman I, Zahirovic S, Ziade N, Bannuru RR, McAlindon T, Nomier MA, Singh JA, Christensen R, Tugwell P, Schünemann H, Akl EA. Arayssi T, et al. Among authors: singh ja. Clin Rheumatol. 2018 Nov;37(11):2947-2959. doi: 10.1007/s10067-018-4245-5. Epub 2018 Aug 10. Clin Rheumatol. 2018. PMID: 30097896

7

Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream?

Singh JA. Singh JA. Ann Rheum Dis. 2019 Feb;78(2):153-154. doi: 10.1136/annrheumdis-2018-213694. Epub 2018 Oct 9. Ann Rheum Dis. 2019. PMID: 30301716 No abstract available.

8

Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital Perspective.

Miller GD, Singh JA. Miller GD, et al. Among authors: singh ja. Rheum Dis Clin North Am. 2019 Feb;45(1):39-51. doi: 10.1016/j.rdc.2018.09.004. Rheum Dis Clin North Am. 2019. PMID: 30447745 Review.

9

Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction?

Day AL, Singh JA. Day AL, et al. Among authors: singh ja. Drugs Aging. 2019 Jun;36(6):493-510. doi: 10.1007/s40266-019-00653-0. Drugs Aging. 2019. PMID: 30953327 Review.

10

Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid Arthritis.

Singh JA. Singh JA. JAMA. 2019 Jul 23;322(4):309-311. doi: 10.1001/jama.2019.9056. JAMA. 2019. PMID: 31334773 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

830 results

Search Page